Zdrowie i gospodarka · 27/09/2023
FDA Reopens Comment Period for Artificial Intelligence in Drug Manufacturing Discussion Paper
The Food and Drug Administration is reopening the comment period for its discussion paper on Artificial Intelligence in Drug Manufacturing, allowing for updates and new information to be submitted.
Source: Federal Register — Food and Drug AdministrationOpen original release →